This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
Vivian Xie
12 Jan 2026

Shaping the future of self-injection: Ypsomed's innovations at Pharmapack's 25th anniversary

Pharmapack 2026 marks a significant milestone as it celebrates its 25th anniversary, bringing together global leaders in pharmaceutical packaging and drug delivery. In this exclusive interview, Ypsomed, a pioneering developer and manufacturer of subcutaneous self-injection solutions, shares insights into their innovative product lineup and their vision for the future of self-injection.

From the award-winning YpsoLoop® platform, which combines sustainability with patient convenience, to cutting-edge solutions like CliniPilot® and Clear to Clinic™, Ypsomed showcases how they are revolutionising drug delivery. The interview also highlights their participation in the Innovation Hub, where visitors can explore groundbreaking projects like YpsoDot® and YpsoFlow®, and emphasises the importance of collaboration and knowledge exchange at this landmark event.

What exciting innovations or products will you be showcasing at Pharmapack 2026?

At Pharmapack 2026, visitors can look forward to discovering how Ypsomed is advancing the future of self-injection. We will, of course, present our award-winning new platform YpsoLoop – the pre-filled autoinjector uniting sustainability and patient convenience.

Other key highlights will be Clear to Clinic™, a solution that provides customers with a significantly faster path to clinic, and CliniPilot®, an innovative add-on for our autoinjectors, which transforms them into smart, connected devices, enabling connected clinical trials.

We’ll also showcase YpsoFlow, our spring-driven, pre-filled pen platform, designed for GLP-1 and peptide therapies. Its trusted usability, future-proof design, and platform flexibility have been very well received by the market, offering customers a smooth path to launch.

And in our Innovation Hub, visitors can take a look into our innovation pipeline to explore selected projects that illustrate how future solutions in drug delivery are gradually taking shape. These include YpsoDot, our pre-filled, cartridge-based pull-push pen designed for multiple injections of a fixed dose.

YpsoLoop® - Uniting sustainability and patient convenience

 

 

 

 

Why did you choose to exhibit at this event?

Pharmapack is one of the key conferences on our industry’s event calendar, and as the leading developer and manufacturer of subcutaneous self-injection solutions, Ypsomed’s presence is essential. The event brings together experts from pharma and biotech companies, industry partners, consultants, and global leaders in pharmaceutical packaging and drug delivery. This makes it the ideal place to exchange ideas, share expertise, and gain valuable insight into emerging trends that shape the future of our field. 

YpsoFlow® - Offering trusted usability and a smooth path to market

 

 

 

Who would you like to meet at the event?
As the reliable partner of pharmaceutical and biotech companies for more than 40 years, we maintain close relationships across the industry, and Pharmapack is always a great opportunity to strengthen these and create new ones.

We look forward to meeting our existing customers to exchange updates and explore how we can further support their current and next-generation therapies. At the same time, we warmly welcome companies that are looking for innovative self-injection solutions and want to benefit from our proven platform approach and expertise.

We also value meeting industry partners and peers to exchange perspectives and spark new collaborations across the wider drug delivery ecosystem, reflecting our ongoing commitment to making self-care simpler and easier. 

CliniPilot® - Leveraging connectivity to empower, enrich and derisk clinical trials

 

 

 

 

 

 

 

 


Discover more about Pharmapack 2026 here.

Mentioned Companies
Ypsomed AG
View company profile
Vivian Xie
Editor - Custom Content

Related News